.
BioEnterprise

Meet our portfolio companies

Select Categories
Viewing Companies
Categories All Categories BioTech & Pharma Medical Device & Diagnostics Health IT & Services
Companies All Companies Current Portfolio Companies Exited Portfolio Companies
  • 21 MedTech

    21 MedTech provides novel biomaterials and 3D printing for the orthopedic market.

    Funding

    Angels

    Stage

    Preclinical
  • 3D Urologic

    3D Urologic is a developer of a surgically implanted medical device to repair and restore urinary bladder function due to neurologic or anatomic bladder dysfunction.

    Funding

    Angels, Founders

    Stage

    Preclinical
  • 7Signal

    7signal offers a comprehensive performance management solution for WLAN networks. 7signal Sapphire© fills the gaps in enterprise WLAN network solutions by adding end user point of view network Quality of Service monitoring and extensive remote troubleshooting capabilities to any WLAN network.

    Funding

    Allos Ventures, Mutual Capital Partners Funds, North Coast Angel Fund, Ohio TechAngels, Akron BioInvestments Funds, JumpStart, TechColumbus, Finnvera, Taronga Development, Tekes

    Stage

    Commercial
  • Aatru Medical

    Aatru Medical develops a negative pressure wound therapy device. The bandage delivers a partial vacuum to the wound area in order to increase circulation in the wound bed, reduce wound exudate and increase granulation tissue formation.

    Funding

    Founders

    Stage

    Preclinical
  • Abeona Therapeutics

    Abeona Therapeutics (NASDAQ: ABEO) is an early-stage biotechnology company focused on developing therapies for the deadly childhood genetic diseases Sanfilippo (SF) Syndrome Type A and Type B. The company's two lead products, ABX-A and ABX-B, uniquely deliver the therapeutic product to the central nervous system with the aim of reversing the effects of the genetic errors that cause the disease.

    Funding

    Cure Sanfilippo Foundation, Sanfilippo Research Foundation (SRF), Team Sanfilippo, Abby Grace Foundation, National MPS Society, Stop Sanfilippo and Sanfilippo B Foundation (Spain), Foundation Sanfilippo (Switzerland), Red Sanfilippo Foundation (Mexico), Soros Fund Management, Perspective Life Science Fund

    Stage

    Clinical
  • Adjuvant Polymers

    Adjuvant Polymers is commercializing a durable, rechargeable polymer-bound antimicrobial platform to effectively control microbial activity and odors for medical/healthcare and personal care applications. Pre-510(k) testing is underway by validation partners and customers.

    Stage

    Preclinical
  • Aeromics Inc.

    Aeromics is developing new small molecule therapeutics, exploiting a novel target for the treatment of CNS edema. The company will exploit the founders' expertise in the biological control of water and gas permeation in pathological and normal tissues.

    Funding

    Grants, Broadview Ventures, Connecticut Innovations, Minerva Bridge, Angels and Archangels

  • Affinity Therapeutics

    Affinity Therapeutics is developing new drug therapies based on its sustained-release delivery platform in regenerative medicine, oncology and advanced wound therapy.

    Funding

    Grants

    Stage

    Preclinical
  • Akrotome Imaging

    Akrotome Imaging focuses on the clinical translation of core research into new approaches to clinical practice and standards of care using guided surgery, therapeutic monitoring, companion diagnostics and inflammatory disease management.

    Funding

    Founders and grants

    Stage

    Preclinical
  • AlgiSys

    AlgiSys is developing a low cost, fermentation-based production process for commercially important omega-3 fatty acids. The proprietary process will be scalable and commercial production is planned within 3 years.

    Funding

    Angel Investors

    Stage

    Clinical
  • AllTech Medical Systems

    With operations in Cleveland (USA) and Chengdu (China), AllTech Medical Systems designs, manufactures, and distributes medical diagnostic Magnetic Resonance Imaging (MRI) products, serving the global MRI market with a state-of-the-art superconducting product family.

    Stage

    Commercial
  • Apollo Medical Devices

    Apollo Medical Devices is developing a single-drop, low-cost point-of-care blood analyzer system.

    Funding

    Innovation Fund, MAGNET MPACT Grant, Northeast Ohio Student Venture Grant, Ohio Third Frontier Technology Validation Startup Fund

    Stage

    Preclinical
  • APTO Orthopaedics

    Apto Orthopaedics’ first device is designed to improve the care of children with spinal deformities by eliminating the need for repetitive, painful and costly surgeries.

    Funding

    Austen BioInnovation Institute in Akron and Akron Children’s Hospital

    Stage

    Preclinical
  • ARIS Teleradiology

    Founded in 2007, ARIS Radiology was created through a partnership of Summa Health System and Akron Radiology. Today, ARIS is a national radiology group with one of the nation's largest networks of subspecialized radiologists, as well as a robust IT platform designed to streamline workflow and speed performance. The practice serves over 130 hospitals and healthcare systems in 31 states.

    Funding

    Great Point Partners, Summa Health System, Akron Radiology

    Stage

    Commercial
  • Arteriocyte

    Arteriocyte’s flagship product family, the Magellan® platelet and stem cell separation platform allows surgeons to rapidly prepare concentrated blood products for use in surgery. Other cellular applications under development include proprietary stem cell and tissue based therapies for cardiovascular disease, orthopedic, sports medicine and wound healing applications.

    Funding

    DW Healthcare Partners, Medtronic, Comerica, Case Technology Ventures, Department of Defense, Significant Grant Funding.

    Stage

    Commercial
  • Athersys

    Athersys (NASDAQ: ATHX) is developing MultiStem®, a patented, adult-derived “off-the-shelf” stem cell product platform, for multiple disease indications in the areas of neurological, cardiovascular disease, inflammatory and immune disease, as well as other areas. The company currently has several clinical stage programs and a portfolio of preclinical programs that we are advancing toward clinical stage development.

    Funding

    Aspire Capital, Radius Ventures, Orbimed, MPM, Hambrecht & Quist, A.M. Pappas Ventures, RA Capital Management, Accipiter Capital, Angiotech, Blue Chip, Invesco, Primus, Western Technology, Piper Jaffray & Co., William Blair & Company, First Analysis, Senmed Medical Ventures, Biotechnology Value Fund Partners, Van Wagoner Capital, NEOMed Management, Cogene Ventures, Crestwood Capital Partners, DRW Venture Partners

    Stage

    Clinical
  • BioInvision

    BioInvision has developed equipment and software to monitor biodistribution of labeled proteins or cells. The company is continuing to develop applications and algorithms for the pre-clinical market and has won several competitive awards from NIH and other agencies. These awards are being used to grow applications of cryo-imaging in stem cells, toxicology, and nanoparticle imaging agent/drug delivery.

    Funding

    Grants

    Stage

    Commercial
  • Biolectrics

    Biolectrics is a medical product developer combining medical, biological, and electrical research to create pioneering new technologies designed to treat severe gum disease, known as periodontal disease, with a family of oral care devices called OraFlow™.

    Funding

    GLIDE, North Coast Opportunity Fund, Angel Investors

    Stage

    Preclinical
  • BioMotiv

    BioMotiv is a therapeutic development company that accelerates discoveries into medicines through an innovative, mission-driven model that efficiently aligns collaborations and capital for the benefit of inventors, investors, physicians and patients.

    Funding

    University Hospitals, Harrington Family, Nationwide Medical Insurance, Takeda Pharmaceutical, Biogen

    Stage

    Preclinical
  • Blue Spark Technologies

    Blue Spark Technologies produces thin, flexible printed battery solutions that can be customized to meet specific application needs, including the pharmaceutical, chemical, healthcare and medical diagnostics industries.

    Funding

    Key Capital Corporation, SubBridge Partners, Early Stage Partners, ORIX Capital

    Stage

    Commercial
  • CardioInsight

    CardioInsight (acquired by Medtronic) has developed a novel, non-invasive advanced cardiac mapping system to map electrical disorders of the heart. The Company’s ECVUE™ system is the first, non-invasive mapping system to provide simultaneous, 3D, multi-chamber mapping and localization of cardiac arrhythmia mechanisms.

    Funding

    Draper Triangle, JumpStart, Case Technology Ventures, Haissaguerre Ventures, West Capital, DVX Capital Partners

    Stage

    Clinical
  • Cell Targeting

    Cell Targeting (acquired by BioTime) is developing a family of novel homing peptides to enhance targeting of therapeutic cells to specific tissues or organs. The company's technology has both clinical and research applications with a portfolio of 15 target organs and tissues.

    Funding

    Toucan Ventures, DARPA

    Stage

    Preclinical
  • CellPrint Biotechnology

    CellPrint Biotechnology develops effective therapies for precisely targeted patient populations. The CellPrint™ platform allows ultra sensitive detection and precise quantification of molecular expression so that measurements can be assigned to specific types of human cells.
  • Centerline Biomedical

    Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system to navigate catheters and guide wires (and ultimately devices) in the 3D anatomy of vascular disease patients. This system will empower surgeons to perform safer, more accurate, and more efficient endovascular procedures.

    Funding

    Cleveland Clinic, Angels, Ohio Third Frontier

    Stage

    Clinical
  • ChanTest

    ChanTest (acquired by Charles River Labs) is an ion channel focused company providing both drug safety and drug discovery and development assays for commercial clients. The company features the most extensive library of ion channel-expressing cell lines available on the market.

    Funding

    Ampersand Ventures

    Stage

    Commercial
  • Checkpoint Surgical

    Checkpoint Surgical a spinout company from NDI Medical, has developed an FDA approved single use nerve location and protection device for intraoperative use by surgeons. The product is useful in over 2 million orthopedic, ENT, neurological and plastic surgeries.

    Funding

    NDI Healthcare Ventures, JumpStart, Medical Growth Fund, OTF, First Analysis

    Stage

    Commercial
  • Cleveland BioLabs

    Cleveland BioLabs (NASDAQ: CBLI) is developing new drugs to protect human tissues from injury caused by acute stresses such as radiation, chemotherapy and ischemias. The company is also leveraging its expertise in apoptosis to develop novel cancer therapeutics.

    Funding

    Sunrise Equity Partners, Enable Growth Partners

    Stage

    Clinical
  • Cleveland Diagnostics

    Cleveland Diagnostics (formerly AnalizaDx) is developing applications of its proprietary platform for the in vitro cancer diagnostic market. The technology is a fundamentally different method for biomarker identification and quantification that addresses the clinical problems posed by natural biological variation in protein levels.

    Funding

    JumpStart, Strategic Partner

    Stage

    Preclinical
  • Cleveland Heart

    Cleveland Heart is a partnership between the Cleveland Clinic and TransWorld Medical Devices. The company is developing the SMARTHEART© VAD, which is the only continuous flow VAD that automatically adjusts pumping flow for the patient based on activity levels and physical requirements. The design incorporates a completely suspended rotating element for limitless mechanical lifespan, and also allows for remote monitoring capability.

    Funding

    Second Generation Fund, Power Heart Consortium

    Stage

    Preclinical
  • Cleveland HeartLab

    Cleveland HeartLab is involved in the discovery and validation of molecular biomarkers and their development into products that aid in the diagnosis and treatment of a variety of diseases. The initial focus is on Myeloperoxidase (MPO), a diagnostic marker of cardiovascular risk, and the company has received 510(k) clearance to market its first biomarker, CardioMPO.

    Funding

    HealthCare Ventures, Excel Venture Management, Glengary Ventures, Zapis Capital, Second Generation, Mutual Capital Partners, Bratenahl Capital Partners, Merck Global Health Innovation, Angel Investor, Advantage Capital Partners

    Stage

    Commercial
  • Cleveland Medical Devices

    Cleveland Medical Devices is a medical services and device manufacturer of innovative home monitoring solutions for patients with sleep apnea.

    Stage

    Commercial
  • CoAg

    CoAg develops a medical device used to stop nose bleeds primarily formulated for anticoagulated patients.
  • Compass Biomedical

    Compass Biomedical, a contract service provider, develops and manufactures platelet-derived products for cell culture, wound care, and ophthalmic applications.

    Stage

    Clinical
  • Complion

    Complion provides a comprehensive Regulatory e-System that increases the quality and efficiency of clinical trials through standard processes and best practices developed in collaboration with leading academic medical centers, health systems, and research sites.

    Funding

    Flashstarts, Angel Investors, Ohio Tech Angels

    Stage

    Commercial
  • COMS Interactive

    COMS Interactive has developed a Software as a Service (SaaS) Disease Management system of integrated clinical and management tools. Deployment of the Daylight IQ product suite dramatically improves the quality of care residents receive in long-term care (skilled nursing) facilities, while driving increased occupancy and revenue.

    Funding

    Portal Capital, Summit Partners, Angel Investors, Zapis Capital, Summit Partners

    Stage

    Commercial
  • Copernicus Therapeutics

    Copernicus Therapeutics is a leader in the emerging field of “nano” nucleic acid therapeutics and delivery systems.  The Company’s proprietary platform technology enables new classes of therapeutic agents for the safe and efficient delivery of DNA, RNA, and shRNA.

    Funding

    Bio Asia, Veron International, Cystic Fibrosis Foundation, GeneChem Management

    Stage

    Clinical
  • CorMetrics

    CorMetrics is a developer of sensor-based interventional devices for the cardiology market. CorMetrics has entered into an exclusive arrangement with a Fortune 50 partner that has developed a new generation of ultra-miniature MEMs sensors to help optimize individualized healthcare

    Stage

    Preclinical
  • CornerStone Medical Services

    Cornerstone Medical Services is a comprehensive home health care equipment and services company. CornerStone partners with hospitals to improve the discharge process for patients and physicians, coordinate home care services and equipment, and conduct disease management programs.

    Funding

    Summa Enterprise Group

    Stage

    Commercial
  • Covariance Biosciences

    Covariance Biosciences is perfecting robust methodologies to reduce the cost of focused next generation sequencing to allow simultaneous analysis of thousands of DNA samples for defined genetic subsets in large populations.
  • CoverMyMeds

    CoverMyMeds works with electronic health record systems (EHRs), health plans, pharmacy systems and prescribers to initiate, transmit and track the status of PA requests within the clinical workflow. CoverMyMeds was the first, and remains the only all drug, all payer prior authorization solution.

    Funding

    Medical Growth Fund, JumpStart Ventures, Saas Capital, Angel Investors, Francisco Partners

    Stage

    Commercial
  • Cryothermic Systems

    Cryothermic Systems (formerly LifeCore Technologies) is a medical device company that has developed a novel approach to selectively cooling the brain thereby inducing mild therapeutic hypothermia. The EXCEL Cerebral Cooling System is a non-invasive, easy to use, 10 second solution to effectively cool the brain after cardiac arrest, stroke, or traumatic brain injury.

    Funding

    JumpStart, Ohio TechAngel Fund, Blue Tree Allied Angels, North Coast Angel Fund, TechColumbus

    Stage

    Commercial
  • Dapcel

    Dapcel is a research biotechnology company focused on the development of strategies for optimization of enhanced protein production in any desired host organism. Dapcel utilizes a unique approach for gene redesign that takes into account the importance of rare codons for protein folding, and results in high yields of correctly folded soluble proteins.

    Funding

    Self-funded

    Stage

    Commercial
  • DATATRAK International

    DATATRAK International (NASDAQ: DTRK) provides an all-in-one solution to empower clinical users and service providers with the components to design, deliver and manage clinical trials.

    Stage

    Commercial
  • Diasome

    Diasome is focused on developing novel liver hepatocyte targeting systems for injectable insulin therapies to improve the treatment of Type 1 and Type 2 diabetes. The company has developed a cell-targeted nanotechnology insulin additive designed to solve the insulin distribution problem in diabetes.

    Stage

    Clinical
  • Emanate Wireless

    Emanate Wireless develops devices that monitor the usage, utilization, and maintenance of healthcare equipment through the company’s cloud-based service.

    Funding

    Angels

    Stage

    Commercial
  • Enforcer e-Coaching

    Enforcer e-Coaching is an email-based health coaching company offering a series of interactive, personalized wellness programs.

    Funding

    JumpStart

    Stage

    Commercial
  • EP Technologies

    EP Technologies develops atmospheric, non-thermal plasma technology for application to biological interfaces such as skin and tissue treatment, surface sanitizing, and material modification for improved biocompatibility

    Stage

    Preclinical
  • Eris Medical Technologies

    ERIS Medical Technologies offers comprehensive and automated solutions that quickly and efficiently identify missing and noncompliant charges for health care providers. Its products are driven by a proprietary rules logic engine that boasts over 375,000 algorithms with code pairing capability and clinical leading practice guidelines. 

    Funding

    GLIDE Fund

    Stage

    Commercial
  • Explorys

    Explorys (acquired by IBM) addresses the national need to leverage big data in healthcare for the improvement of medicine and delivery of care. The company creates a healthcare database platform from numerous and diverse financial, operational and medical record source systems.

    Stage

    Commercial
  • Exsurco

    Exsurco delivers breakthrough solutions for debridement, excision and grafting for those suffering from burns, wounds, infections and other skin disorders, capitalizing on a technological legacy honed by years of innovative “cutting” experience. With inventive expertise and compassionate commitment, Exsurco’s tools enable precise, accurate and fast tissue removal.

    Stage

    Commercial
  • Extremity Development Corporation

    Extremity Development Corporation is an accelerator developing foot and ankle braces and small bone orthopedic surgical devices.

    Stage

    Preclinical
  • FlexLife

    FlexLife (formerly Zin Medical; acquired by LifeWatch) is a remote monitoring company with a proprietary web-based digital health platform that enables home monitoring of multiple patient vital signs for the early prediction of atrial fibrillation.

    Funding

    Zin Technologies, Cleveland Clinic

    Stage

    Clinical
  • FMI Medical Systems

    FMI Medical Systems is developing an ultra-high resolution multimodality imaging technology using fused 3D molecular and anatomic imaging, radioisotopes, X-ray micro CT, and optical surface imaging. Initial applications include a breast imaging system to detect the presence of cancer and functional neurological imaging for early Alzheimer's detection. 

    Funding

    Chinese Investment Group

    Stage

    Preclinical
  • ForTec Medical

    ForTec Medical mobilizes surgical technologies—including the broadest array of lasers—to hospitals, surgery centers, and physician offices on an as-needed basis. Physicians enjoy the latest generation of surgical technologies, delivered and operated by trained ForTec technicians. Hospitals and healthcare professionals enjoy ForTec’s pay-per-use model, which avoids costly capital investments, technology obsolescence risk, and staffing headaches. 

    Funding

    Self-funded

    Stage

    Commercial
  • Future Path Medical

    Future Path Medical has developed a device for clinical fluid management solutions using innovative sensor technology. The patented and FDA cleared UroSense© device is applied to urine management in home-care and rehab hospitals, and soon in the hospital ICU and ORs.

    Funding

    Angel Investors

    Stage

    Commercial
  • Ganeden Biotech

    Ganeden Biotech (product acquired by Schiff Nutrition) has developed superior strains of probiotics which break down barriers inherent to most common strains of probiotics. Ganeden technology can be found in diverse areas such as probiotic functional foods and beverages, and animal health products.

    Funding

    DSM Capital, Capital Resource Partners, Fairbridge Venture Partners

    Stage

    Commercial
  • GenomOncology

    GenomOncology is a healthcare technology company that enables precision medicine by transforming genomic data into actionable information.

    Funding

    Zapis Capital, JumpStart, TriStar Technology Ventures

    Stage

    Commercial
  • GLC Biotechnology

    GLC Biotechnology, a spinout from Cleveland State University, will exploit the commercial potential of its novel technology for DNA methylation analysis. The method is more sensitive, specific and much more cost effective than currently available alternatives. The initial focus will be on new diagnostics for colorectal and other cancers.

    Funding

    Grants

    Stage

    Preclinical
  • GraphSQL

    GraphSQL provides database and analytics software for the life sciences and beyond. Capable of massive scale (hundreds of million nodes and edges) and speed (multiple times NSA benchmark), GraphSQL can aid in the detection of fraud in insurance claims as well as identification of ‘patients like me’ for clinical guidance.

    Funding

    AME Cloud Ventures, Data Collective, Milliways Ventures

    Stage

    Commercial
  • Haima Therapeutics

    Haima Therapeutics’ synthetic platelet technology provides hemostasis for traumatic bleeding and treats certain blood disorders. The company’s lead product, SynthoPlate, renders rapid hemostasis in a dose dependent fashion comparable to natural platelets in the acute bleeding setting.

    Stage

    Preclinical
  • Homecare Collection Services

    Homecare Collection Services (acquired by Invacare, NYSE: IVC) provides a customizable suite of cash flow enhancement services to the HME/DME and homecare markets. Since 2003, HCS has consistently built both its customer base and reputation for industry leading patient-pay services.

    Stage

    Commercial
  • Human Arc

    Human Arc’s focus is on reimbursement recovery for healthcare providers, revenue enhancements for health plans, and healthcare coverage cost savings for employers. Since its founding, the company has specialized in eligibility screening and enrollment assistance for governmentally funded healthcare coverage, producing over a billion dollars in eligibility-related income for its clients.

    Funding

    Self-funded

    Stage

    Commercial
  • Huneo

    Huneo provides a comprehensive system to monitor human health in real time, and to provide access to historical data collected from patients so that comparisons can be made between different time periods to establish long term health trends.

    Funding

    Self-funded

    Stage

    Beta
  • Hyr Medical

    Hyr Medical develops a transparent, web-based marketplace connecting doctors directly with part-time shift openings.

    Funding

    GLIDE Innovation Fund

    Stage

    Preclinical
  • ImageIQ

    ImageIQ is an Imaging Contract Research Organization combining software engineering with biomedical and imaging expertise to provide quantitative visual analysis that enhances R&D and product efficacy/safety testing for research, medical device and pharmaceutical organizations.

    Funding

    Cleveland Clinic Innovations, Angel Funding

    Stage

    Commercial
  • Infinite Arthroscopy

    Infinite Arthroscopy offers a wireless arthroscopic camera system. This system provides improvements for conducting arthroscopic surgeries, such as the elimination of the weight, complexity, and mess of wires and cables.

    Funding

    Angels

    Stage

    Preclinical
  • Innovative Medical Equipment

    Innovative Medical Equipment specializes in the development, manufacturing, licensing and distribution of medical equipment directly to end-consumers and to physicians. IME is focused on delivering common sense solutions by leveraging existing technologies and manufacturing techniques.

    Stage

    Commercial
  • Intelligent Mobile Support

    Intelligent Mobile Support connects a mobile workforce to experts and critical information for customers including med-tech customer service, clinical applications training personnel and home healthcare providers. The Software-as-a-Service improves individual and team performance while lowering an organization's operational costs. 

    Funding

    JumpStart, Pittsburgh Equity Partners, North Coast Angel Fund, TechColumbus, Shaker LaunchHouse

    Stage

    Commercial
  • Intellirod Spine

    Intellirod Spine (formerly OrthoData) is developing a wireless implantable microelectronic spinal rod strain sensor. This innovative strain monitoring system will allow spine surgeons to objectively assess the strain on implanted spinal fusion rods.

    Funding

    Kentucky Seed Capital Fund, Akron BioInvestments Funds, JumpStart, Angel Investors, Commonwealth Seed Capital, Cardinal Equity Partners, Queen City Angels

    Stage

    Preclinical
  • Intellis EPM

    Intellis EPM (product acquired by Carefx) is Enterprise Performance Management for Healthcare. The company’s business intelligence tool combines data analytics tools and dashboards to provide operational insight to senior hospital management.

    Stage

    Commercial
  • iRxReminder

    iRxReminder delivers a complete Smartphone-based clinical drug trial data management system for research centers. The system consists of web-based management software and a smartphone application. The application allows customizable surveys, medication reminding, podcast-style education modules, and study activity tracking in real time.

    Funding

    Grants, Angel Investors

    Stage

    Commercial
  • Juventas Therapeutics

    Juventas Therapeutics is developing novel regenerative medicine technologies from the Cleveland Clinic for treatment of cardiovascular disease. The company's lead product, Stromal Derived Factor-1 (SDF-1) has been shown to significantly improve cardiac function through promoting cell survival and revascularization following a heart attack. The company is also pursuing opportunities in the areas of critical limb ischemia and wound repair.

    Funding

    Triathlon Medical Ventures, New Science Ventures, Takeda Pharmaceuticals, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, Blue Chip Ventures, JumpStart, North Coast Angel Fund, Glengary LLC, Global Cardiovascular Innovation Center, Venture Investors LLC, Tri-State Growth Capital, X Gen, Green Cross Holdings, POSCO Capital

    Stage

    Preclinical
  • Leading Age Supplies

    Leading Age Supplies provides medical supplies for long-term and the home care market. They are in the market with a disinfecting wash cloth and are currently developing a urinary catheter.

    Funding

    Self-funding

    Stage

    Preclinical
  • Lexi-Comp

    Lexi-Comp (acquired by Wolters Kluwer Health) was founded in 1978 to create custom reference handbooks for clinical laboratories. Since then, Lexi-Comp has evolved its content base and technology solutions to provide clinically relevant, real-time information at the point-of-care in knowledge areas that include pharmacology, interactions, diagnostic procedures and laboratory tests, pharmacogenomics, poisoning and toxicology, dentistry, infectious diseases, and patient education.

    Stage

    Commercial
  • LifeMedix

    LifeMedix™ is an innovator of medical resuscitation devices and point-of-care information technology for civilian and military first-response, emergency medical and trauma units. The company is developing an ultra-portable rapid circulatory resuscitation device to help treat and prevent shock in the pre-hospital setting.

    Funding

    GLIDE Fund, Grants, Angel Investors

    Stage

    Preclinical
  • Lobesity

    Lobesity is developing a pharmaceutical agent to prevent obesity. The agent is initially targeting those patients with non-alcoholic fatty liver disease and hepatic steatosis.

    Funding

    Preclinical

  • Lumitex Medical Devices

    Lumitex Medical Devices creates, manufactures and distributes unique, cool devices for medical illumination. Its patented technologies are used to treat jaundice in infants and help surgeons better visualize deep surgical cavities.

    Stage

    Preclinical
  • Lumoptik

    Lumoptik Inc. has developed innovative precision guidance systems for medical devices utilizing its exclusive patent-pending Light Assisted Breach Assessment (LABA) technology. Applications include the Precision Eye Guidance System, Precision Epidural Guidance System, Precision Vascular Guidance System, Precision Drug Delivery System and Precision Joint Guidance System.

    Funding

    Private Angels, Grants

    Stage

    Preclinical
  • Luna Living

    Luna Living provides outpatient addiction treatment. Biochemical recovery is addressed with nutritional supplementation and IV NAD+ Therapy.

    Stage

    Commercial
  • m2m Imaging

    m2m Imaging offers a wide range of clinical and preclinical MRI products including cryogenic coils, phased array coils and conventional coils, as well as imaging accessories for MRI, PET, CT, and SPECT environments (animal beds, phantoms, physiological monitoring and heating). 

    Funding

    Amphion Innovations, Mayport Venture Partners, Channel Capital, Yenni Capital, Riverside Investment Partners

    Stage

    Preclinical
  • MedInvent

    MedInvent is the manufacturer of the NasoNeb family of products, created to provide optimal intranasal drug delivery solutions while also improving outcomes, reducing patient risk, reducing cost of care and reducing suffering.

    Funding

    Self-funded

    Stage

    Commercial
  • MediQuant

    MediQuant is a software firm providing Medicare billing, reimbursement, and legacy data solutions for health care providers, primarily hospitals and health networks.

    Funding

    Self-funded

    Stage

    Commercial
  • Mercury Biomed

    Mercury Biomed is commercializing novel and proprietary technology to safely and effectively adjust and maintain a patient’s core body temperature. Its WarmSmart and SmartCool products are currently in clinical trials and are targeted for launch in 2016 and 2018, respectively, pending FDA 510 (k) clearances.

    Stage

    Clinical
  • Meridian Medical Systems

    Meridian Medical Systems (MMS) has developed, beta tested and obtained FDA clearance to market a full line of Digital Radiography (DR) devices and systems that will enable X-ray imaging providers to transform their systems into the digital age at a fraction of the cost. The system will improve image access, speed and quality, improve process and workflow efficiency, and optimize radiation exposure of x-ray imaging.

    Stage

    Commercial
  • Miach Medical Innovations

    Miach is developing sensor-equipped endotrachial and feeding tubes that wirelessly signal their location within the body, and detect misplacement or unintended movement.

    Funding

    GLIDE Innovation Fund

    Stage

    Preclinical
  • Micro Office Systems

    Micro Office Systems provides a cloud-based, patient-engagement platform that streamlines doctor-patient communications. The system’s integration with existing practice management and electronic health record systems extends and automates services to patients while saving time and money for medical practices.

    Stage

    Commercial
  • Milo Biotechnology

    Milo Biotechnology is developing novel therapies based on follistatin, a protein that increases muscle mass and strength. Milo is targeting rare neuromuscular diseases, initiating a Phase I/II clinical trial in Becker muscular dystrophy and inclusion body myositis.

    Funding

    North Coast Opportunity Fund, JumpStart, Rev1 Ventures

    Stage

    Clinical
  • Movable

    MOVABLE (acquired by DHS Group) provides a corporate wellness program resulting in increased productivity and lower healthcare costs. Using their product, MOVband, and program, MOVchallenge, employees are given the awareness and motivation needed to make lasting lifestyle changes.

    Stage

    JumpStart, Founders Factory, GLIDE, Hatch, Angel Investors
  • My Health Place

    My Health Place provides consulting and educational services in cost containment, disease management, healthcare plan options and nutrition.

    Funding

    Angel Investors

    Stage

    Commercial
  • NanoVision Diagnostics

    NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system 1000 times more sensitive than an optical microscope. This system is able to detect molecular changes in a standard biopsy slide. The company will offer its proprietary technology as a diagnostic service.

    Funding

    Private Angels, North Coast Angels

    Stage

    Clinical
  • NDI

    NDI is s a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies that are intended to restore lost neurological function, prevent damage and reduce the painful effects of disease and injury. NDI provides the capital to: identify and develop technologies, launch and grow companies, and take them to successful exits. In 2008, NDI sold its first product to Medtronic for $42 million.

    Funding

    Angels, Grants

    Stage

    Commercial
  • NeoProteomics

    NeoProteomics is a provider of research services and tools that help clients unravel the complexities of pharmaceutical and biological research.  The company currently provides expert services and tools to numerous partner companies and research laboratories worldwide.

    Funding

    Strategic Partner, GLIDE

    Stage

    Commercial
  • Nervive

    Nervive is developing a non-invasive medical device to treat ischemic stroke that improves blood flow to the brain at the earliest opportunity, reducing the lasting impact of ischemic stroke and improving neurological condition while facilitating use of existing treatments.

    Funding

    Grants, Angels

    Stage

    Clinical
  • NeuroLogix Technologies

    NeuroLogix Technologies develops technology to conduct neurological evaluations. The company’s system uses an iPad and sophisticated algorithms to create a neurological baseline to determine the extent of a patient's condition and to monitor recovery.

    Stage

    Commercial
  • Neuros Medical

    Neuros Medical is developing neurostimulation therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, is focused on elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine.

    Funding

    Boston Scientific, RiverVest Ventures, Case Technology Ventures, JumpStart, North Coast Angel Fund, Ohio TechAngel Fund, Glengary Ventures, Queen City Angel Fund, Blue Tree Allied Angels, ModelVest, Physician Investment Group, TechColumbus

    Stage

    Clinical
  • NeuroWave

    NeuroWave is a medical device manufacturer (ISO & FDA compliant) of innovative non-invasive brain monitors for clinical applications in anesthesia, critical care, neurology & emergency medicine. NeuroWave's flagship product is the NeuroSENSE® Monitor, the latest generation of brain monitors for patient-customized anesthesia and sedation, now cleared for sale in markets recognizing the CE mark. 

    Funding

    Grants

    Stage

    Clinical
  • NovelMed

    NovelMed’s platform technologies have led to the development of monoclonal antibodies and small molecule therapies for the treatment of arthritis, cardiovascular disease, stroke and cancer.

    Funding

    Significant Grant Funding

    Stage

    Preclinical
  • O2 RegenTech

    O2 RegenTech is commercializing a hyper-oxygenated hydrogel wound dressing technology used to increase healing outcomes in chronic wounds.

    Funding

    GLIDE, TVSF, Ohio Third Frontier

    Stage

    Preclinical
  • OncoStatyx

    OncoStatyx is developing cancer therapies utilizing differentiation therapy for treatment of triple negative breast cancer.

    Stage

    Preclinical
  • OnShift

    OnShift offers on-line scheduling and employee communications solutions specifically designed for individual and multi-site long term care organizations. OnShift optimizes the scheduling process, tightly manages labor costs, prevents overtime, and automates the resolution of call-offs through automated text messaging, integrated voice response and email.

    Funding

    Early Stage Partners, Jumpstart, North Coast Angels, Draper Triangle, West Capital Advisors, Glengary LLC, HLM Venture Partners, Fifth Third Capital

    Stage

    Commercial
  • Orbital Research Inc.

    Orbital Research Inc. has developed an FDA cleared, extended-wear dry physiologic electrode with a clean ECG signal. Orbital's dry electrode improves patient comfort and compliance by eliminating the need for aggressive skin preparation and the use of irritating adhesives and electrolytic gels. The dry electrodes may be used for home ECG monitoring and a variety of other wearable medical devices.

    Funding

    Grants

    Stage

    Commercial
  • OrthoHelix

    OrthoHelix Surgical Designs (acquired by Tornier NV, NASDAQ: TRNX) is developing and marketing a comprehensive set of instruments and implants for use in foot, ankle, and hand reconstruction surgery. The FDA-approved OrthoHelix product line is designed specifically for and by orthopedic surgeons and podiatrists who surgically repair small bones and joints.

    Funding

    Mutual Capital Partners, River Cities Capital, JumpStart, Ohio Third Frontier, D.B. Kay Designs, Synogen Development Group

    Stage

    Commercial
  • PartsSource

    PartsSource is the leading provider of replacement parts solutions for healthcare. With well over $100 million in annual sales, the company has over 200 employees and is responsible for several groundbreaking industry firsts. These include a patented suite of technology solutions featuring an algorithm-driven procurement engine and supplier-ranking module, a medical parts marketplace offering one-stop shopping for millions of replacement parts and a mobile application providing portable access to the marketplace. 

    Funding

    Polaris Ventures, Primus Capital

    Stage

    Commercial
  • PediaCath

    PediaCath is a joint venture formed by PediaWorks and Medikit, a Japanese catheter manufacturer. The company specializes in catheters for pediatric applications. 

    Funding

    PediaWorks, Medikit

    Stage

    Commercial
  • PediaWorks

    PediaWorks spearheads the identification and validation of unmet pediatric medical device needs, while collaborating with a network of medical device experts and academic institutions to aid in product design and development.

    Funding

    Grants

    Stage

    Preclinical
  • Perfusion Solutions

    Perfusion Solutions is a Cleveland Clinic spin-out formed to develop small, high output ventricular assist devices. The technology platform’s scalable design enables a full range of support across the continuum of cardiovascular care, from catheter pumps to chronic implants for partial to complete assist.

    Funding

    Grants

    Stage

    Preclinical
  • PeriTec BioSciences

    PeriTec Biosciences is developing a hybrid solution which uses biology in combination with stents in a way which vastly reduces the likelihood of the adverse reactions that accompany other stents. In addition, optimal blood flow is assured in specifically designed stents.

    Funding

    Angels, Grants

    Stage

    Clinical
  • Plexar Imaging

    Plexar Imaging is a developer of image quality management systems for medical imaging devices. Plexar Imaging has invented a universal image quality technology that, for the first time, allows CT image quality to be standardized regardless of scanner make and model.

    Funding

    Self-funded, GLIDE, North Coast Opportunity Fund

    Stage

    Preclinical
  • Polgenix

    Polgenix is a small biotech company whose aim is to solve structures of G protein-coupled receptors for drug discovery purposes using a unique protein expression system.

    Funding

    Grants

    Stage

    Commercial
  • Population Genetics

    Population Genetics is the developer of technologies for high sensitivity and high specificity next generation sequencing detection of genetic variants which enhances the clinical power of next generation sequencing in infectious disease applications.

    Stage

    Preclinical
  • Proxy Biomedical

    Proxy Biomedical is a leading innovator in the development of next generation medical products using proprietary biomaterials technology. Proxy is developing implantable meshes and engineered biomaterials for surgical applications, tissue regeneration, and tissue repair.

    Funding

    Self-funded

    Stage

    Commercial
  • Quality Electrodynamics QED

    Quality Electrodynamics (QED) is a global developer, manufacturer and supplier of advanced medical equipment electronics. Current products include cutting edge MRI radiofrequency (RF) antennas/coils for diagnostic imaging at the full range of magnetic field strengths.

    Funding

    Grants, Strategic Partners

    Stage

    Clinical
  • Red5 Pharmaceuticals

    Red5 Pharmaceuticals develops innovative diagnostics and therapeutic agents against cancer. The company performs the chemical synthesis and pharmaceutical testing of non-natural nucleosides as novel anti-cancer agents against hematological cancers and solid tumors.

    Funding

    Ohio Third Frontier

    Stage

    Preclinical
  • Renovo Neural

    Renovo Neural Inc. is a specialized preclinical research organization offering services that revolutionize biological research and development of neural therapies. Renovo’s preclinical model systems and automated electron microscopy applications provide high-quality standard and customizable solutions for basic science, preclinical and clinical research.

    Stage

    Clinical
  • ReXceptor

    ReXceptor is developing disease modifying small molecule therapeutics for the treatment of Alzheimer’s disease and other neurological disorders.

    Funding

    GLIDE Innovation Fund, BrightFocus Foundation, Alzheimer’s Drug Discovery Foundation, Case Western Reserve University, JumpStart

    Stage

    Preclinical
  • Ricerca

    Ricerca (acquired by Main Market Partners) collaborates with pharmaceutical and biopharmaceutical developers by providing a comprehensive, integrated suite of services to accelerate drug development that combines nonclinical support for drug candidate selection with analytical and chemical development expertise, to bring drug candidates through all phases of development.

    Funding

    Main Market Partners

    Stage

    Commercial
  • RIS Logic

    RIS Logic (acquired by Merge) developed a comprehensive radiology information system that fuses information, images and dictation into a single-desktop system, eliminating the complexity, cost and time associated with the development of separate interfaces.

    Stage

    Commercial
  • Roscoe Medical

    Roscoe Medical is a leading specialty distributor of respiratory supplies and replacement parts to the home medical equipment market.

    Funding

    River Associates, Tenex Capital Management

    Stage

    Commercial
  • SAIDO Learning

    SAIDO Learning™ is an innovative proven method for improving the quality of life for older adults suffering from Alzheimer’s disease and other symptoms of dementia. SAIDO is a non-pharmaceutical intervention that addresses memory loss among older adults with cognitive impairment.

    Stage

    Commercial
  • SarahCare Adult Day Care Services

    SarahCare Adult Day Care Services is one of the fastest growing national providers of adult day services. SarahCare differentiates itself by providing comprehensive health-related services through its adult day services hub which offers seniors and their families’ unique programs that are tailored for their specific needs in an activity based environment. 

    Funding

    Self-funded

    Stage

    Commercial
  • Sator Therapeutics

    SATOR Therapeutics develops a range of non–pathogenic, attenuated or engineered strains of individual viruses for the treatment of various types of cancer.

    Stage

    Preclinical
  • SecuReach

    SecuReach is a web-based patient communication system that manages test tracking and follow-up. The company has developed an innovative and cost-effective solution for ensuring that patient tests are completed and that results are communicated properly.

    Funding

    Angels

    Stage

    Commercial
  • Securus Medical Group

    Securus Medical Group is developing clinical tools to monitor core body temperature within body cavities. Thermal injury to the tissue due to energy from various sources can create damage to surrounding tissue. Securus will provide clinicians a simple to use, real-time, noncontact, thermal map of body cavity tissue temperature. This information will guide the physician to achieve the desired clinical outcome without risk of injury to surrounding tissue.

    Funding

    RiverVest Venture Partners, JumpStart, 3X5 Special Opportunity Fund, University of Michigan Investment in New Technology Startups, Boston Scientific

    Stage

    Preclinical
  • Sensor Development Corporation

    Sensor Development Corporation offers a diagnostic sensor for volatile breath biomarkers. This sensor targets the detection of pulmonary aspergillosis, a fungal infection affecting the lungs.

    Funding

    Grants

    Stage

    Preclinical
  • Sequentia

    Sequentia is a value-based care platform that focuses on transition of care for all involved – patients, in-hospital and in-home, hospitals, and post-acute care providers. The platform drives process improvement and care outcomes and improves clinical and business results for healthcare providers.

    Funding

    GLIDE, Angel investors

    Stage

    Commercial
  • Simbionix

    Simbionix USA (acquired by 3D Systems) is the leading developer and marketer of interactive medical simulators and simulation software for minimally invasive procedures. Target markets include medical schools and hospitals for physician training and medical device companies as a tool for new product development, user training and marketing. Simulators may also be used to practice complex procedures prior to surgery.

    Funding

    River Cities Capital, Early Stage Partners, Astro

    Stage

    Commercial
  • SLICE Manufacturing

    SLICE Manufacturing Studios develops custom and mass manufacturing of orthopedic and other medical metallic implants using cutting edge 3D printing and additive manufacturing technologies. It does so via contract manufacturing arrangements with medical device manufacturers, including its NextStep sister companies.

    Funding

    Theken Companies

    Stage

    Commercial
  • Socrates Software

    Socrates integrates disparate hospital administrative software systems to facilitate reporting on operational metrics that are difficult to obtain but critical in improving the hospital’s operational efficiencies. Metrics include: operating room utilization, hospital bed requirements and length of stay, direct and indirect costs, the measurement and management of outcomes, and efficiency of care. 

    Funding

    University Hospitals

    Stage

    In Development
  • SPR Therapeutics

    SPR Therapeutics, a spinoff of NDI Medical, has developed a proprietary peripheral nerve stimulation platform to address a critical unmet need for non-narcotic, less invasive, reversible, and cost effective treatments for acute, post-operative and chronic pain. The company is sponsoring clinical studies to evaluate this technology in multiple high-potential pain indications.

    Funding

    NDI Healthcare Fund, JumpStart, Grants, Public Square Partners, GLIDE

    Stage

    Clinical
  • StreamlineMD

    StreamlineMD (a wholly owned subsidiary of PRC Medical), delivers an affordable, reliable Electronic Medical Records (EMR) solution to small and midsized physician practices. The company’s product is the first EMR solution to combine software, local training, support, and remote hosting into a subscription-based service.

    Funding

    Angels

    Stage

    Commercial
  • Superior Products

    Superior Products, LLC (acquired by Engineered Controls International) manufactures and provides logistics for a complete line of gas management systems, compressed gas fittings, and assemblies and manifolds for the alternative fuel, welding, cryogenic, medical and specialty gas markets throughout the world.

    Funding

    Engineered Controls International, Audax Group, CITIC Capital, Windjammer Capital Investors

    Stage

    Commercial
  • Surgical Theater

    Surgical Theater, LLC is a Virtual Reality and Image Guidance software company for healthcare. Its products include: the SuRgical Planner™ (SRP), the first and only patented and FDA-cleared platform for neurosurgical pre-operative planning; and the Surgical Navigation Advanced Platform (SNAP), which connects to standard operating room navigation systems and provides advanced imaging capabilities including multiple 3D points of view.

    Funding

    GLIDE Fund, Angel investors, OurCrowd, Wolfpack Ventures, HTC, Shanghai Creation Investment Management Company

    Stage

    Commercial
  • Synapse Biomedical

    Synapse Biomedical has developed the FDA approved NeuRx Diaphragm Pacing System©, a neurostimulation technology designed to help spinal cord injury and ALS patients decrease their dependency on mechanical ventilation. The technology is also being developed for diaphragm conditioning in respiratory short-term intensive care settings.

    Funding

    Vivo Ventures, Palo Alto Investors, Case Technology Ventures, JumpStart

    Stage

    Commercial
  • Talis Clinical

    Talis Clinical’s suite of IT solutions provides clinical and operational management throughout Perioperative Care. The company offers guidance that can expose opportunities to improve patient care in real-time at the point of care.

    Funding

    Self-funded

    Stage

    Commercial
  • Teraphysics

    Teraphysics has developed patented ultra-high speed 5G data delivery using a millimeter-wave amplifier.

    Stage

    Clinical
  • The Smithers Group

    The Smithers Group companies provides independent testing, consulting, information or compliance services. The Smithers Group includes Smithers Apex, Smithers Avanza, Smithers Pira, Smithers Quality Assessments, Smithers Rapra, and Smithers Viscient. Each Smithers Group company provides technology-based services focused on a defined market.

    Funding

    Founders

    Stage

    Commercial
  • The Walden Companies

    The Walden Company is a developer of urology and surgical tools based on physician-driven ideas. The company’s product, the Relief Stent, is a ureteral stent with a suture separated pigtail, reducing reflux, encrustation, and trigone muscle irritation.

    Funding

    GLIDE, Angel

    Stage

    Preclinical
  • Therapy Partners

    Therapy Partners (acquired by HealthPRO Rehabilitation) contracts with long-term care facilities to provide and manage physical, occupational and speech therapy services to residents and clients.

    Funding

    Angels

    Stage

    Commercial
  • TheraVasc

    TheraVasc is developing treatments for peripheral artery disease and diabetic neuropathy based on an oral formulation of sodium nitrite.

    Funding

    JumpStart, Portal Capital, North Coast Angel Fund, Ohio TechAngels, Physician Investment Group

    Stage

    Clinical
  • Thermalin Diabetes

    Thermalin Diabetes, LLC has identified a portfolio of novel heat-stable and fast-acting insulin analogs. The company is leveraging breakthroughs with significant IP built on 25 years of research on insulin by Dr. Michael Weiss, Chairman of Biochemistry at Case Western Reserve Medical School (CWRU).

    Stage

    Preclinical
  • Thermedx

    Thermedx is improving the Perioperative Fluid Management space with its FluidSmart™ System – the only FDA 510(k) cleared fluid management device capable of fluid pressure or flow control, on-demand fluid warming, and fluid deficit monitoring for Gynecology, Urology, and Orthopedics.

    Funding

    Angels

    Stage

    Commercial
  • Timocco

    Timocco offers an online, therapeutic gaming environment specifically designed for children with special needs to develop motor, cognitive, and communication abilities.

    Stage

    Commercial
  • Toad Medical Corporation

    Toad Medical Corporation has developed the custom Toad Anti-Gravity (TAG) Foot Brace which completely unloads the foot and ankle complex and eliminates pressure and sheer. By enabling the patient to ambulate during recovery time without the need for crutches, muscular atrophy is dramatically reduced.

    Funding

    Self-funded, Angel Investors

    Stage

    Commercial
  • Tradex International

    Tradex International (Acquired by Cardinal Health) is the nation's leading supplier of medical exam and food service grade disposable latex, nitrile and vinyl gloves.

    Stage

    Commercial
  • Trailhead Biosystems

    Trailhead Biosystems automates cell culture and drug discovery experiments using an innovative system of robotic hardware and data analysis.
  • Ureteral Stent Company

    Ureteral Stent Company develops and commercializes physician-driven urological medical device innovations. The company currently develops The RELIEF Stent for the treatment following kidney stones which allows easier insertion and removal, less irritation to the bladder, and reduced flow of urine back to the kidney.

    Stage

    Clinical
  • Vectorious Medical Technologies

    Vectorious Medical Technologies is the developer of the Vectorious system, a minimally-invasive implanted device and external home unit that monitors congestive heart failure to increase patient quality of life and reduce admission rates.

    Stage

    Clinical
  • ViewRay

    ViewRay, Inc. (OTCQB: VRAY) is a publically held company that develops advanced radiation therapy technology for the treatment of cancer. The MRIdian® system provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient’s anatomy.

    Funding

    OrbiMed Advisors, Fidelity Biosciences, Kearny Venture Partners, Aisling Capital, Siemens Venture Capital, Cowealth Medical Holding Company, JumpStart, Montrose Capital, Xeraya Capital

    Stage

    Commercial
  • Viscus Biologics

    Viscus Biologics is the developer and manufacturer of allograft and xenograft platforms that are unique in size, strength and biologic components. The company produces its proprietary products as well as providing custom product development for partners.

    Stage

    Commercial
  • Visum Therapeutics

    Visum Therapeutics is developing a small molecule therapeutic to treat Stargardt's disease, a degenerative condition that leads to blindness and is the most common form of inherited juvenile macular degeneration.

    Stage

    Preclinical
  • Wendell-Alan

    Wendell-Alan (acquired by Torex) manufactures and distributes hot and cold therapy devices used for general muscle discomfort and post-surgical areas.

    Stage

    Commercial
  • Western Oncolytics

    Western Oncolytics takes the most cutting-edge cancer treatments that show promise in laboratory research and proves their efficacy to patients in clinical trials. Their lead therapy, WO-12, delivers therapeutic genes that train the immune system to fight a wide range of cancers with limited side effects and in combination with other treatments.

    Funding

    Angels, Tiberius II

    Stage

    Preclinical
  • Whole Health Management

    Whole Health (acquired by Walgreen, NYSE: WAG) enables employers to provide self-insured healthcare to employees ranging from primary and urgent care to preventative health and wellness programs while also reducing costs and increasing employee productivity.

    Funding

    Angels

    Stage

    Commercial
  • Within3

    Within3’s advanced collaboration software solutions allow life sciences and other healthcare organizations to communicate safely and seamlessly with external stakeholders – including physicians, patients, allied health professionals, payers, and healthcare executives.

    Funding

    Easton Capital, Angels, Drummon Road Capital, NY Venture Fund, BlueMesa Partners

    Stage

    Commercial
  • YourOmics

    YourOmics provides tools to the academic and industrial biological research communities interested in basic and translational research, drug development and biomarker-based patient stratification. The software integrates, analyzes, and visualizes gene and protein-based pathways and networks.

    Stage

    Commercial
  • Zuga Medical

    Zuga Medical designs, manufactures, and markets innovative dental implant systems. The system allows dental professionals to reduce chair time, eliminate outsourced patient and laboratory services, and allow general dentists to perform the complete patient service with fewer visits.

    Stage

    Clinical